Targeting the centrosome and polo-like kinase 4 in osteosarcoma

Fergal C Kelleher1,2, Jeska Kroes1, Jeremy Lewin3

  • 1Department of Medical Oncology, St. James Hospital, Dublin, Ireland.

Carcinogenesis
|December 4, 2018
PubMed

Insights

Extra centrosomes, driven by polo-like kinase 4 (PLK4), promote tumorigenesis and aneuploidy. Functional p53 halts cell cycle in response, suggesting PLK4 inhibitors like CFI-400945 may treat osteosarcomas.

Area of Science:

  • Cell Biology
  • Cancer Biology
  • Genetics

Background:

  • The role of extra centrosomes in tumorigenesis has been debated.
  • Polo-like kinase 4 (PLK4) overexpression induces centrosome amplification and aneuploidy.
  • Centrosome amplification is linked to spontaneous tumor formation in mice.

Purpose of the Study:

  • To investigate the link between PLK4, centrosome amplification, and tumorigenesis.
  • To explore the role of p53 in response to extra centrosomes.
  • To evaluate the potential of PLK4 inhibitors in osteosarcoma treatment.

Main Methods:

  • Overexpression of PLK4 to induce centrosome amplification.
  • Analysis of cellular aneuploidy and tumor formation in mice.
  • Investigation of p53 pathway activation and cell cycle arrest.
  • Examination of osteosarcoma tissues for associated genetic features.

Main Results:

  • PLK4 overexpression leads to centrosome amplification, aneuploidy, and tumorigenesis.
  • p53-deficient tissues tolerate extra centrosomes, while p53-proficient tissues arrest proliferation.
  • Extra centrosomes activate the PIDDosome complex, leading to p53 stabilization and cell cycle arrest.
  • Osteosarcomas exhibit aneuploidy, chromosomal rearrangements, and p53 dysfunction.

Conclusions:

  • PLK4-induced centrosome amplification is a driver of tumorigenesis.
  • The p53 pathway acts as a critical barrier against extra centrosomes.
  • PLK4 inhibitors, such as CFI-400945, show potential therapeutic value for osteosarcoma.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
Centrioles and Centrosomes01:13

Centrioles and Centrosomes

Most animal cells comprise a pair of centrioles together called a centrosome. The cell duplicates its centrosome and contains two centrosomes side-by-side, which begin to move apart during the prophase. As the centrosomes migrate to two different sides of the cell, microtubules start extending from each centrosome toward the other end. The mitotic spindle is composed of the centrosomes and their emerging microtubules.
Near the end of the prophase, also called late prophase or...
5.9K
Centrosome Duplication02:25

Centrosome Duplication

The primary microtubule organizing center (MTOC) in animal cells is the centrosome. A centrosome has two cylindrical centrioles at its core. Each centriole consists of nine sets of three microtubules held together by proteins. The centrioles are positioned at right angles to each other and surrounded by a shapeless protein cloud called the pericentriolar matrix, or pericentriolar material (PCM).
To ensure that each daughter cell receives a centrosome after cell division, centrosome duplication...
5.0K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.6K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
670